Finch Therapeutics Group, Inc. (FNCH)
Total Valuation
FNCH has a market cap or net worth of $110.81 million. The enterprise value is $9.62 million.
Market Cap | 110.81M |
Enterprise Value | 9.62M |
Important Dates
The latest earnings date was Monday, May 16, 2022, before market open.
Last Earnings Date | May 16, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
FNCH has 47.56 million shares outstanding. The number of shares has increased by 238.69% in one year.
Shares Outstanding | 47.56M |
Shares Change (YoY) | +238.69% |
Shares Change (QoQ) | +21.24% |
Owned by Insiders (%) | 51.37% |
Owned by Institutions (%) | 22.27% |
Float | 22.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.23 |
PB Ratio | 0.62 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.31, with a Debt / Equity ratio of 0.03.
Current Ratio | 7.31 |
Quick Ratio | 6.38 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -33.10%, which is considered low. The company has a ROIC of -112.20%.
Return on Equity (ROE) | -33.10% |
Return on Assets (ROA) | -30.10% |
Return on Capital (ROIC) | -112.20% |
Revenue Per Employee | $81,127 |
Profits Per Employee | -$363,735 |
Employee Count | 189 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
Total Price Change | -89.46% |
50-Day Moving Average | 2.72 |
200-Day Moving Average | 7.73 |
Average Volume (30 Days) | 961,857 |
Short Selling Information
The latest short interest is 755,194, so 1.59% of the outstanding shares have been sold short.
Short Interest | 755,194 |
Short % of Shares Out | 1.59% |
Short % of Float | 3.37% |
Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, FNCH had revenue of $15.33 million and -68.75 million in losses. Earnings per share was -$1.45.
Revenue | 15.33M |
Gross Profit | 15.33M |
Operating Income | -70.59M |
Net Income | -68.75M |
EBITDA | -65.49M |
EBIT | -68.75M |
Earnings Per Share (EPS) | -$1.45 |
Balance Sheet
The company has $106.93 million in cash and $5.74 million in debt, giving a net cash position of $101.19 million or $2.13 per share.
Cash & Cash Equivalents | 106.93M |
Total Debt | 5.74M |
Net Cash | 101.19M |
Net Cash Per Share | $2.13 |
Book Value | 179.79M |
Book Value Per Share | 3.78 |
Working Capital | 105.86M |
Cash Flow
In the last 12 months, operating cash flow was -$77.57 million and capital expenditures -$8.01 million, giving a free cash flow of -$85.57 million.
Operating Cash Flow | -77.57M |
Capital Expenditures | -8.01M |
Free Cash Flow | -85.57M |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -460.39% and -448.35%.
Gross Margin | 100.00% |
Operating Margin | -460.39% |
Pretax Margin | n/a |
Profit Margin | -448.35% |
EBITDA Margin | -427.11% |
EBIT Margin | -448.40% |
FCF Margin | -558.08% |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -62.04% |
FCF Yield | -77.22% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -238.69% |
Shareholder Yield | -238.69% |
Analyst Forecast
The average price target for FNCH is $24.14, which is 936.05% higher than the current price. The consensus rating is "Buy".
Price Target | $24.14 |
Price Target Difference | 936.05% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |